You Can Now Use Whoop Blood Tests Without Registration.
Whoop, best known for its screenless fitness tracker , continues to expand its presence in healthcare. Today, the company announced that its Whoop Advanced Labs blood testing service will now be available without a Whoop subscription. Additionally, Whoop Advanced Labs now includes the Galleri test for early detection of multiple cancers, developed by biotech company Grail.
Since Whoop launched its Advanced Labs service last fall , connecting blood test results to the Whoop app’s continuous health monitoring system required a Whoop subscription. Now, lab tests are available as a standalone product for consumers, continuing the trend of companies like Whoop expanding beyond wearables and creating comprehensive, all-in-one health monitoring platforms.
How Whoop Advanced Labs Works
Advanced Labs, powered by Quest Diagnostics, covers cardiovascular, metabolic, hormonal, and inflammatory conditions with a suite of panels, some comprehensive, others tailored to specific goals. The process is simple on paper: purchase a test (Whoop says it starts at around $150), schedule a donation in the Whoop app, and then visit a local clinic to donate. Whoop says at-home donations via the mobile app will soon be available in select areas. Each test is administered by a licensed healthcare professional, and the resulting report is reviewed by a licensed physician before appearing in the app with what Whoop describes as “clear, actionable recommendations” rather than just a collection of numbers and reference ranges.
The new Gallery test works slightly differently. It’s a one-time blood draw that detects a signal common to over 50 types of cancer, many of which currently lack a standard screening protocol. It’s important to note that it detects a signal indicating the possible presence of cancer, not a diagnosis, and is intended to complement, not replace, screenings already recommended by your doctor. Advanced Labs’ services are currently not covered by insurance, but purchases may be eligible for reimbursement through an HSA or FSA , though please check with your insurance plan administrator before purchasing.
What to consider
Whoop’s existing user base already consists primarily of serious athletes and enthusiasts seeking to optimize their health—precisely the kind of people who are willing to seek more data about their bodies, regardless of whether that data is actually beneficial to their health. Removing the membership requirement significantly expands the user base, but it’s fair to question whether everyone who buys the $150 test understands what they’re signing up for when they receive their results, or whether they have a plan in place in the event of an unexpected result.
Comprehensive biomarker panels can provide a wealth of useful information: unusually high cholesterol levels, vitamin deficiencies, early signs of insulin resistance, and so on. At the same time, they can yield numerous borderline or ambiguous results, causing concern without clear next steps. Simultaneously analyzing dozens or more hundreds of biomarkers increases the likelihood that something will fall outside the “normal” range entirely by chance, and not every detected indicator will lead to meaningful medical action.
Early detection tests for multiple cancers, such as Galleri, are still a relatively new technology, and consumers should be prepared to discuss false positive and false negative results with their healthcare provider, as well as what to do if a positive result occurs. I’m currently among those closely watching how wearable technology companies are increasingly penetrating territory once reserved exclusively for the doctor’s office.